The chairman put forward requirements for the work in the coming year
Release time:
2023-01-29
2022 held on February 18 , Jiang Xiaomeng, secretary of the party Committee and chairman of the group company, made a summary speech entitled "unite as one, face up to difficulties, and fully complete the annual production and operation objectives" in view of the current market situation and existing problems faced by the company, give direction and request for company 2023 . Jiang Xiaomeng pointed out that in order to achieve long-term and stable business development, enterprises must clearly understand the situation, fully understand and grasp the pulse of the times, clarify various national policies, and carry out targeted business activities. In the past few years, the epidemic has repeatedly continued to affect, raw material prices have fluctuated, electricity prices have risen across the board, infrastructure and real estate sectors have been depressed, resulting in a decline in the efficiency of the cement industry; the pharmaceutical industry has poor circulation channels and limited end-use consumption, and the impact is also very serious. The past year has been full of hardships, but the efforts and achievements are also worthy of recognition.
Talking about the work in
2023, Jiang Xiaomeng said that at present, development is regarded as the top priority from the central government to the local government. Peak enterprise managers should focus on the following changes to realize self-reform and promotion: changing mental mode and habitual thinking, daring to do things that have not been done, and using innovative spirit, use new ideas, new methods, and new measures to solve the company's current problems; change its own vision pattern, keep up with the pace of the times, be brave and willing to accept new things, not only to learn advanced technology from excellence and benchmarking, We must also learn from their experience and ideas, and put an end to working behind closed doors; change the ecosystem, enhance the symmetry of information, and have a high degree of sensitivity and full industry sense of smell, accept the cutting-edge information of the industry in a timely manner, understand the development trend of information technology, gain insight into the market environment and strategic choices of enterprises, and help enterprises achieve long-term and steady development; change learning methods, improve learning ability, especially the ability to apply what they have learned, apply what they have learned to production, and truly realize technological innovation; dare to take responsibility, dare to take responsibility, love their own enterprises, be loyal to their own enterprises, serving your own company, sharing weal and woe with the company, we must always take the maximization of corporate benefits as the starting point to make various decisions. At present, there are many peak industries, large spans and wide regions. The specific conditions of enterprises are different. How can we better create benefits? Jiang Xiaomeng put forward six
"to " , that is, to seek benefits from the market, to continuously improve the control ability of marketing channels, the ability to predict and grasp market opportunities, the ability to serve customers, the ability to build brands, and the ability to manage customer relationships. We should seek benefits from costs, carry out a series of work strictly around reducing costs and increasing efficiency, and focus on our own reality, from the procurement cost, production process, production technology, labor productivity, energy conservation and environmental protection ability, product output, these cost-related links; to seek benefits from intelligence, through intelligent and digital applications to improve labor productivity; to seek benefits from management, improve management skills and management capabilities, and improve the per capita profit-making ability of each enterprise; to seek benefits from innovation, and strive to carry out product innovation and process innovation, make out the characteristics and advantages of peak enterprises; seek benefits from safety, truly strictly implement the safety production responsibility system and accountability system, do a good job in safety production strictly, practically, and carefully, and resolutely build a safety bottom line. Jiang Xiaomeng pointed out that
2023has obvious opportunities and difficulties for the peak. The group should unite as one, face up to the difficulties, use wisdom and courage to fully and exceed the annual production and operation targets, and greet the 30th anniversary of the group's listing 30# with excellent results. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page